Virtu Financial LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2022$44,000
+214.3%
72,452
+451.9%
0.00%
+300.0%
Q2 2022$14,00013,1270.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 72,452$44,0000.00%
HighMark Wealth Management LLC 6,966$4,0000.00%
UBS Group AG 26$00.00%
WELLS FARGO & COMPANY/MN 46$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$28,0000.00%
STATE STREET CORP 14,455$9,0000.00%
MILLENNIUM MANAGEMENT LLC 23,683$15,0000.00%
MORGAN STANLEY 10,611$7,0000.00%
BlackRock Inc. 74,192$45,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders